Gabapentin
Product Images NDC 10544-186

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 10544-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (10544 186 30 53746 102 05)

FDA Label Image

Dc2d0eb8-figure-01 (Dc2d0eb8 Figure 01)

FDA Label Image

Dc2d0eb8-figure-02 (Dc2d0eb8 Figure 02)

FDA Label Image

Dc2d0eb8-figure-03 (Dc2d0eb8 Figure 03)

FDA Label Image

Dc2d0eb8-figure-04 (Dc2d0eb8 Figure 04)

Dc2d0eb8-figure-04 (Dc2d0eb8 Figure 04)
This text displays a table that shows the percentage of responders at endpoint for two different studies, identified as Study 1 and Study 2. However, the purpose or nature of the studies is not available as there is not enough context.*
FDA Label Image

Dc2d0eb8-figure-05 (Dc2d0eb8 Figure 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.